In patients affected either with AD and PD were detected higher levels of HO-1 expression in astrocytes of the hippocampus and cerebral cortex, together with enhanced serum and plasma levels of HO-1 [132,133]. This evidence concerns the gene HMOX1 and Parkinson disease.